home / stock / gmtx / gmtx short
Short Information | Gemini Therapeutics Inc. (NASDAQ:GMTX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 426,107 |
Total Actual Volume | 3,524,436 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 21,305 |
Average Short Percentage | 12.44% |
Is there a GMTX Short Squeeze or Breakout about to happen?
See the GMTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-29-2022 | $1.36 | $1.35 | $1.41 | $1.35 | 62,860 | 22,725 | 36.15% |
12-28-2022 | $1.23 | $1.35 | $1.36 | $1.18 | 116,537 | 32,764 | 28.11% |
12-27-2022 | $1.7 | $1.35 | $1.71 | $1.33 | 2,681,173 | 291,324 | 10.87% |
12-23-2022 | $1.53 | $1.55 | $1.61 | $1.53 | 60,710 | 1,030 | 1.7% |
12-22-2022 | $1.55 | $1.55 | $1.63 | $1.55 | 100,102 | 38,468 | 38.43% |
12-21-2022 | $1.5539 | $1.54 | $1.6301 | $1.52 | 55,479 | 5,428 | 9.78% |
12-20-2022 | $1.61 | $1.6 | $1.69 | $1.57 | 92,079 | 13,350 | 14.5% |
12-19-2022 | $1.53 | $1.6 | $1.61 | $1.47 | 43,680 | 2,858 | 6.54% |
12-16-2022 | $1.52 | $1.555 | $1.57 | $1.5103 | 25,350 | 1,353 | 5.34% |
12-15-2022 | $1.67 | $1.545 | $1.7 | $1.52 | 51,834 | 3,093 | 5.97% |
12-14-2022 | $1.66 | $1.65 | $1.7 | $1.63 | 9,579 | 2,012 | 21% |
12-13-2022 | $1.69 | $1.65 | $1.7 | $1.62 | 24,368 | 415 | 1.7% |
12-12-2022 | $1.65 | $1.65 | $1.68 | $1.64 | 6,446 | 123 | 1.91% |
12-09-2022 | $1.66 | $1.65 | $1.7 | $1.62 | 12,767 | 1,259 | 9.86% |
12-08-2022 | $1.56 | $1.65 | $1.69 | $1.56 | 26,473 | 39 | 0.15% |
12-07-2022 | $1.65 | $1.65 | $1.66 | $1.64 | 2,728 | 809 | 29.66% |
12-06-2022 | $1.675 | $1.62 | $1.7 | $1.61 | 35,926 | 2,200 | 6.12% |
12-05-2022 | $1.66 | $1.7 | $1.73 | $1.66 | 25,808 | 2,752 | 10.66% |
12-02-2022 | $1.6 | $1.72 | $1.73 | $1.6 | 37,034 | 3,272 | 8.84% |
12-01-2022 | $1.71 | $1.63 | $1.7152 | $1.61 | 53,503 | 833 | 1.56% |
News, Short Squeeze, Breakout and More Instantly...
Gemini Therapeutics Inc. Company Name:
GMTX Stock Symbol:
NASDAQ Market:
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria PR Newswire WATERTOWN, Mass. , Dec. 27, 2022 /PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on t...
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP) PR Newswire AURORA study designed to evaluate bitopertin as a potential disease-modifying treatment for adults with EPP in the United States ...